Literature DB >> 1678801

Accidental astemizole overdose in young children.

K Hoppu1, T Tikanoja, P Tapanainen, M Remes, O Saarenpää-Heikkilä, K Kouvalainen.   

Abstract

6 cases of accidental astemizole poisoning in children have been reported to the Finnish Poison Information Center. The children were aged 1 year 7 months to 3 years 4 months and had taken doses of 2.5 to 16.7 mg/kg, at least twelve times that recommended. In 2 children the overdose was verified by measurement of drug concentrations. Despite measures to prevent drug absorption prolonged QTc-interval, a sign of cardiac toxicity, was found in all 5 children on whom an electrocardiogram was available for analysis, and severe ventricular arrhythmias developed in 1. Young children with accidental astemizole overdose should be carefully monitored in hospital. Similar precautions may be justified in cases of overdose with other selective H1-histamine receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1678801     DOI: 10.1016/0140-6736(91)91101-y

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Cytochrome P450 3A: ontogeny and drug disposition.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

Review 2.  Comparative tolerability of second generation antihistamines.

Authors:  F Horak; U P Stübner
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

3.  Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.

Authors:  Hanna Phan; Matthew L Moeller; Milap C Nahata
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia.

Authors:  S Pohjola-Sintonen; M Viitasalo; L Toivonen; P Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Public health problems and the rapid estimation of the size of the population at risk. Torsades de pointes and the use of terfenadine and astemizole in The Netherlands.

Authors:  R M Herings; B H Stricker; H G Leufkens; A Bakker; F Sturmans; J Urquhart
Journal:  Pharm World Sci       Date:  1993-10-15

Review 6.  Macrolide antibacterials. Drug interactions of clinical significance.

Authors:  N A von Rosensteil; D Adam
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

7.  Possible interactions with terfenadine or astemizole.

Authors:  A D Zechnich; J R Hedges; D Eiselt-Proteau; D Haxby
Journal:  West J Med       Date:  1994-04

Review 8.  H1-receptor antagonists. Comparative tolerability and safety.

Authors:  F E Simons
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 9.  Safety and tolerability of treatments for allergic rhinitis in children.

Authors:  Carlos E Baena-Cagnani
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 10.  Safety of antihistamines in children.

Authors:  A P Ten Eick; J L Blumer; M D Reed
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.